Evaluation of Keyo in Children With Epilepsy
Sponsored by Vitaflo International, Ltd
About this trial
Last updated 9 years ago
Study ID
MCT-Keyo-11/12/15-01
Status
Completed
Type
Interventional
Phase
N/A
Placebo
No
Accepting
3+ Years
All
Not accepting
Healthy Volunteers
Trial Timing
Ended 9 years ago
What is this trial about?
To evaluate the tolerance, acceptability and compliance of Keyo in 20 subjects aged 3 years
and over, with intractable epilepsy or Glut-1 DS on a KD.
What are the participation requirements?
Inclusion Criteria
- 3 years and over
- Confirmed diagnosis of intractable epilepsy or Glut-1 DS
- Children must be currently established on a KD for at least 3 months, taken orally
- Written, informed consent by participant/carer